Yazar "Dursun, Polat" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim
    Öğe
    Basit histerektomi sonrası tanı alan serviks kanserlerine güncel yaklaşım
    (Türk Jinekolojik Onkoloji Derneği, 2014) Güngördük, Kemal; Özdemir, İsa Aykut; Şahbaz, Ahmet; Dursun, Polat; Gökçü, Mehmet; Sancı, Muzaffer; Köse, Faruk; Ayhan, Ali
    Servikal kanser, tüm dünyada jinekolojik kanserlere bağlı ölümlerin önde gelen nedenlerindendir. Pap smear taramasının yaygın kullanımı ile servikal kanser erken tanısı artmaktadır. Ancak, ihmalden ya da olguların yetersiz değerlendirilmesinden dolayı servi-kal kanser tanısı retrospektif olarak histerektomi sonrası konabilmektedir. Radikal parametrektomi ve radyoterapi, basit histerek-tomi sonrası tanı alan servikal kanser olgularındaki iki tedavi modalitesidir. Bu çalışmada, histerektomi sonrası tanı alan servikal kanser olgularının nedenleri, tedavi modaliteleri ve prognozları hakkında kapsamlı bilgi vermeyi hedefledik.
  • Küçük Resim
    Öğe
    Performing gynecologic cancer surgery during the COVID-19 pandemic in Turkey: A multicenter retrospective observational study
    (Wiley, 2020) Dursun, Polat; Dervişoğlu, Haluk; Daggez, Mine; Turan, Taner; Kılıç, Fatih; Moraloğlu Tekin, Özlem; Üreyen, Işın; Toptaş, Tayfun; Demirayak, Gökhan; Önder, Ayşe Büşra; Çelik, Çetin; Bayramoğlu, Denizhan; Güzel, Ahmet Barış; Arıöz, Dağıstan Tolga; Bilir, Filiz; Özdemir, İsa Aykut; Taşçı, Tolga; Karalök, Alper; Karateke, Ateş
    Objective To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID-19) pandemic and the safety of surgical approach. Methods Data of patients operated between March 10 and May 20, 2020, were collected retrospectively. Data were statistically analyzed using IBM Statistical Package for the Social Sciences (SPSS) Statistics for Windows v. SP21.0. Results Data of 200 patients were included. Their mean age was 56 years. Of the patients, 54% (n=108), 27.5% (n=55), 12.5% (n=25), and 2% (n=4) were diagnosed as having endometrial, ovarian, cervical, and vulvar cancer, respectively. Of them, 98% underwent non-emergent surgery. A minimally invasive surgical approach was used in 18%. Stage 1 cancer was found in 68% of patients. Surgeons reported COVID-related changes in 10% of the cases. The rate of postoperative complications was 12%. Only two patients had cough and suspected pneumonic lesions on thoracic computed tomography postoperatively, but neither was positive for COVID-19 on polymerase chain reaction testing. Conclusion Based on the present findings, it is thought that gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to the measures. Postponement or non-surgical management should only be considered in patients with documented infection. Gynecologic cancer surgery should continue during the COVID-19 pandemic while adhering to measures. Only 1% of patients developed COVID-19-related symptoms during the postoperative follow-up period.